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Aims: To compare the ability of the National Early Warning Score (NEWS) and the National Early Warning Score
2 (NEWS2) to identify patients at risk of in-hospital mortality and other adverse outcomes.
Methods: We undertook a multi-centre retrospective observational study at five acute hospitals from two UK
NHS Trusts. Data were obtained from completed adult admissions who were not fit enough to be discharged alive
on the day of admission. Diagnostic coding and oxygen prescriptions were used to identify patients with type II
respiratory failure (T2RF). The primary outcome was in-hospital mortality within 24 h of a vital signs ob-
servation. Secondary outcomes included unanticipated intensive care unit admission or cardiac arrest within
24 h of a vital signs observation. Discrimination was assessed using the c-statistic.
Results: Among 251,266 adult admissions, 48,898 were identified to be at risk of T2RF by diagnostic coding. In
this group, NEWS2 showed statistically significant lower discrimination (c-statistic, 95% CI) for identifying in-
hospital mortality within 24 h (0.860, 0.857–0.864) than NEWS (0.881, 0.878-0.884). For 1394 admissions with
documented T2RF, discrimination was similar for both systems: NEWS2 (0.841, 0.827-0.855), NEWS (0.862,
0.848–0.875). For all secondary endpoints, NEWS2 showed no improvements in discrimination.
Conclusions: NEWS2 modifications to NEWS do not improve discrimination of adverse outcomes in patients with
documented T2RF and decrease discrimination in patients at risk of T2RF. Further evaluation of the relationship
between SpO2 values, oxygen therapy and risk should be investigated further before wide-scale adoption of
NEWS2.
Introduction
Vital signs based aggregate early warning score (EWS) systems,
which assign weights to each vital sign according to the deviation from
assumed normal values, are recommended for routine use in UK hos-
pitals [1,2]. In 2012, the Royal College of Physicians of London (RCPL)
published a proposed National EWS (NEWS) [3], which has now un-
dergone extensive validation [4–6]. In NEWS, oxygen saturations
(SpO2) receive increasing weights for values of 95% or less, and oxygen
therapy receives a flat weight. However, guidance for the management
of patients with type II respiratory failure (T2RF) [7,8], and those
deemed at risk of T2RF before blood gas analysis [7], suggests lower
SpO2 values (88–92%) should be targeted. Consequently, it is suggested
that the NEWS SpO2 weighting system is inappropriate for patients
with/at risk of T2RF [9–11]. Some authors suggest that this weighting
risks inappropriate oxygen therapy for these patients, with potential
deleterious consequences [9,10].
In December 2017, the RCPL published an update to NEWS - the
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National Early Warning Score 2 (NEWS2) [12] - which includes several
modifications to the NEWS vital sign weightings. To account for con-
cerns about NEWS and T2RF, NEWS2 includes a new SpO2 scoring scale
for patients with/at risk of T2RF. This scale, termed SpO2 scale 2 assigns
weights at lower SpO2 thresholds than NEWS and combines these lower
thresholds with weights for the use of supplemental oxygen at higher
SpO2 levels, reflecting the concern of hyperoxia-induced hypercapnic
respiratory failure [12] (see appendix A1). Although the derivation of
these thresholds is not presented, and NEWS2 is as yet unvalidated,
NHS England has endorsed NEWS2′s use in acute and ambulance set-
tings [13], and is considering the use of the Commissioning for Quality
and Innovation (CQUIN) payment system [14,15] to encourage orga-
nisations to implement NEWS2 by March 2019.
In this study, we used a large multi-centre dataset of vital signs to
compare retrospectively the performance of NEWS2 and NEWS. We
studied the performance of NEWS and NEWS2 in three risk groups:
those with documented T2RF; those at risk of T2RF; and patients in
neither of these groups.
Methods
The database for this study was created with Health Research
Authority (reference: 16/SC/0264 and 08/02/1394) approval. The
study protocol is available online [16]; we follow the TRIPOD state-
ment for reporting [17].
Source of data
A database of vital sign observations was collated from adult (aged
at least 16 years) acute admissions to the Oxford University Hospitals
(OUH) group and Portsmouth Hospitals NHS Trust (PH) as part of the
Hospital Alerting Via Electronic Noticeboard (HAVEN) dataset [18].
Clinical staff recorded patients’ vital signs at the bedside using the
System for Electronic Notification and Documentation (SEND, Drayson
Health, www.draysonhealth.com) [19] in OUH and VitalPAC™ (System
C Healthcare, www.systemc.com) in PH [20]. The following data were
recorded: date and time of observation (automatically by SEND/Vi-
talPAC™); heart rate, systolic blood pressure, respiratory rate, body
temperature, neurological status using the Alert-Voice-Pain-Un-
responsive (AVPU) scale, SpO2; and the patient’s inspired gas (air or
supplemental oxygen) at the time of SpO2 measurement. The HAVEN
database also contains administrative and patient demographic in-
formation, and information about the occurrence and timing of cardiac
arrest, unanticipated intensive care unit (ICU) admission and hospital
discharge status (dead/alive). Prescription data from the electronic
patient record is also available within the database for OUH admissions.
Study sites
The study took place at five hospitals – the four hospitals in the OUH
group [The John Radcliffe Hospital (large university hospital), The
Horton General Hospital (small district general hospital), The Churchill
hospital (large university cancer centre) and The Nuffield Orthopaedic
Hospital] and a single large district general hospital, PH.
Participants
All completed adult admissions to the four hospitals comprising the
OUH group (January-December 2016) and to PH (January 2012 -
December 2016) with at least one complete set of vital signs observa-
tions recorded electronically were considered. These study periods re-
present times of full deployment of electronic vital signs documentation
in these hospitals. Patients discharged alive from the hospital before
midnight on the day of admission and those with no vital signs recorded
in the 24 h prior to discharge (as a proxy for patients on end-of-life
pathways) were excluded from the analysis. For the main analysis, we
combined admissions from all hospitals, but we also analysed data from
each hospital trust separately (see appendix A3).
Early warning scores (see appendix A1)
The NEWS2 adjustment for patients with/at risk of T2RF differs
from NEWS in the assignment of weights to measured SpO2 (NEWS
weights SpO2 values below 96%; NEWS2 below 88%). Additionally, for
patients with/at risk of T2RF, NEWS2 assigns weights for SpO2 values
above 92% when receiving oxygen.
Outcome
The primary outcome was in-hospital death within 24 h of an ob-
servation set, in line with previous studies [21,22]. Secondary outcomes
include cardiac arrest, unanticipated ICU admission, and either cardiac
arrest, unanticipated ICU admission, or death within 24 h of an ob-
servation set. We present the results for all secondary outcomes, flag-
ging those where insufficient outcomes exist (< 100), due to sample
size, as recommended in the TRIPOD guidelines [17]. All outcomes
were obtained retrospectively from different clinical information sys-
tems, including the hospitals’ patient administration systems, the ICU
clinical information systems, and the hospitals’ National Cardiac Arrest
Audit (https://ncaa.icnarc.org) databases.
Predictors
Vital sign sets (see above) were recorded using SEND/VitalPAC™.
Where the patient’s conscious level had been assessed only using the
Glasgow Coma Scale (GCS), we converted GCS to an AVPU equivalent
[21]. Vital signs were then assigned weights for NEWS and NEWS2
scores (see appendix A1). The sum of the weights (aggregate score)
results in the NEWS and NEWS2 value for each observation set. SEND
(OUH) uses a modified EWS, CEWS [23], which assigns increasing
weights to SpO2 values less than 94% and does not weight SpO2 values
of 94% or above. Clinical staff entering vital signs data were therefore
unaware of NEWS or NEWS2 scores. VitalPAC™ (PH) uses NEWS. To
allow comparison with published analyses of NEWS [22,24], and in line
with previous vital-signs-based EWS research [25–28], each vital sign
set was analysed as independently associated with the outcome.
Missing data
For the analysis, we considered complete observation sets (i.e., sets
with measurements of all vital signs), in line with previous NEWS stu-
dies [22,24]. The SEND system allows recording of incomplete vital
sign sets, which is discouraged in the VitalPAC™ system. We did an a
priori sub-analysis in which we used multiple imputation, a general-
purpose and widely used approach to missing values [29] which only
occurred in the OUH dataset.
Statistical analysis
Performance of NEWS and NEWS2 was assessed by discrimination
using receiver operating characteristic (ROC) curve analysis (calibra-
tion was not assessed, as the EWS systems do not give estimates of
absolute risk). We also assessed the effect of suggested thresholds for
patient review (aggregate NEWS/NEWS2 scores of 5 or above, or 7 or
above [12]) by reporting sensitivity, specificity and positive predictive
values. We also show SpO2 distributions for three different risk groups
(see below). All analysis was performed using the R statistical software
(v3.4.4) [30] and ROC curves were calculated using the pROC package
[31]. Differences in the area under the ROC curve (AUROC), or c-sta-
tistic, between NEWS and NEWS2 were compared using bootstrapping
(2000 samples) [31]. We did post-hoc sub-analyses of performance by
institution (in light of the different patient numbers contributed). We
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also performed post-hoc efficiency curve analysis (as we were unable to
conduct decision curve analysis as estimates of risk for a given score are
not available).
Risk groups
After exclusion criteria were applied, we categorised each admission
according to the following risk groups:
1 Patients with recorded T2RF, identified using the Adult Oxygen
Prescription form of the current admission (OUH only).
2 Patients at risk of T2RF, identified using the International Statistical
Classification of Diseases and Related Health Problems-10 (ICD-10)
classification for their concurrent or prior admission, with either of
the following groups of diagnosis codes:
a J40-J44 (typically, 88% coded as J44) - patients with Chronic
Obstructive Pulmonary Disease (COPD); or
b J47 – patients with Bronchiectasis; or
c E84 – patients with Cystic Fibrosis; or
d E66 – patients with obesity and/or obesity hypoventilation syn-
drome; or
e G12, G47.3, G70-G71, M95.4, or Q67.8, with J96 – patients with
respiratory failure (J96) and one of the following conditions:
spinal muscular atrophy and other motor neuron disease (G12),
sleep apnoea (G47.3), myasthenia gravis and other myoneural
disorders (G70), muscular dystrophies (G71), acquired deformity
of chest and rib (M95.4), or other congenital deformities of chest
(Q67.8).
3 Patients not at risk of T2RF, i.e., not in groups 1 or 2 above.
We report the performance metrics of each scoring system for each
of these risk groups. We report the results of the SpO2 scale 2 of
NEWS2 in the third risk group (patients not at risk of T2RF) to de-
monstrate the effect of erroneous use of the scale in this population.
Development versus evaluation datasets
NEWS was originally developed using a dataset with admissions to
PH’s Medical Assessment Unit (MAU) [22]. The NEWS2 report does not
identify a development dataset for NEWS2 [12]. The study evaluation
database (HAVEN) includes data from all admissions to OUH and pH for
the periods stated above. Vital sign data for all sites are present from
hospital admission to hospital discharge/death. NEWS2 is re-
commended for use in all the included settings.
Results
Descriptive statistics
A total of 251,266 distinct admissions were included. Fig. 1 shows
the application of inclusion/exclusion criteria, resulting in the final
cohort of admissions. All patients in the final dataset had at least one
complete vital sign set. A total of 48,898 admissions were associated
with patients at risk of T2RF, and 1394 with patients with documented
T2RF (80.3% of whom also belong to the group of patients at risk of
T2RF). Table 1 summarises the admission demographic descriptors and
other clinical information for the three risk groups. Patients in risk
groups 1 (documented T2RF) and 2 (at risk of T2RF) both had higher
mortality rates (and rates of other adverse outcomes) when compared
to patients who were not at risk (i.e. risk group 3).
The distribution of SpO2 values for patients with documented T2RF
is bell-shaped, whereas that for the group of patients who are not at risk
was right skewed (Fig. 2). In patients with documented T2RF, 77.4% of
admissions had at least one recorded SpO2 measurement above 92% on
room air, compared with 98.7% in the non-risk group (Fig. 2).
Performance of early warning scores
Performance metrics for the three risk groups for in-hospital death
are presented in Table 2, and the corresponding ROC curves are re-
presented in Fig. 3. Those for the secondary outcomes are shown in
Table 3.
Results of the sub-analyses by institution are shown in appendix A3.
The effects of using multiple imputation to replace missing vital sign
values are shown in appendix A4.
In patients with documented T2RF, the AUROCs for predicting in-
patient mortality within 24 h for the two scoring systems were as fol-
lows: NEWS 0.862 (95% CI: 0.848 to 0.875); NEWS2 0.841 (0.827 to
0.855) (Table 2). Using a threshold of 5 points, positive predictive va-
lues for NEWS and NEWS2 were 2.5% and 3.0% respectively. In pa-
tients at risk of T2RF, the AUROC for predicting inpatient mortality
within 24 h for the two scoring systems were as follows: NEWS 0.881
(0.878 to 0.884); NEWS2 0.860 (0.857 to 0.864). Using a threshold of 5
points, positive predictive values for NEWS and NEWS2 were 3.2% and
2.7%, respectively.
Our sub-analysis using multiple imputation to deal with missing
values gave similar results (appendix A4).
We calculated efficiency curves (see appendix A2) to compare the
efficiency of NEWS and NEWS2. The curves demonstrate that, for the
few patients with documented T2RF, the use of NEWS2 at the suggested
RCPL cut-offs of 5 and 7 points [12] reduces absolute staff workload by
approximately 11% and 5% respectively, but at the expense of reduced
sensitivity of approximately 10% and 14%, respectively. For patients at
risk of T2RF, the use of NEWS2 at the suggested RCPL cut-offs of 5 and
7 points [13] does not significantly decrease staff workload, but reduces
sensitivity by 5–6%. Finally, if used in error for patients not at risk of
T2RF at the suggested RCPL cut-offs, NEWS2 is slightly more sensitive
than NEWS but, to achieve this, risks doubling the workload.
Discussion
Main findings
This is the first study to evaluate the performance of NEWS2 in
hospitalised patients who have documented T2RF or are at risk of it. For
the primary outcome - in-hospital death within 24 h of an observation –
NEWS2 demonstrated no improvement in discrimination over NEWS
for patients with documented T2RF, but at the suggested RCPL cut-offs
of 5 and 7 points, the positive predictive values (PPV) were higher for
NEWS2 than NEWS. However, for patients at risk of T2RF, NEWS had
superior discrimination and higher PPV compared to NEWS2. When
applied to patients not at risk of T2RF (to simulate the impact of using
NEWS2 in error in such patients) NEWS2 discriminated less well than
NEWS and had lower PPV. Finally, NEWS2 did not improve dis-
crimination for any of the secondary outcomes compared to NEWS.
Modified scores have been suggested to account for chronically al-
tered physiology in patients with respiratory-related conditions
[10–12]. One of these, CREWS [11], improved the positive predictive
value compared to NEWS in patients with or at risk of T2RF (see ap-
pendix A5), but at the expense of decreasing sensitivity for events.
However, such approaches challenge the premise that a universal EWS,
with its attendant advantages, should be employed throughout hospi-
tals. In NEWS2, assigning lower SpO2 thresholds together with heuristic
weights for the use of supplemental oxygen at higher SpO2 values re-
flects the concern of hyperoxia-induced hypercapnic respiratory failure.
However, encoding this concern as undertaken in NEWS2 does not
improve discrimination in any of the three risk groups of admissions.
Given the main purpose of EWS systems is to identify ill or deteriorating
patients, the reduced sensitivity introduced by NEWS2 in patients with
documented T2RF and those at risk of it is a disadvantage compared to
NEWS. This reduced sensitivity could be ameliorated to an extent by
reducing the trigger values for NEWS2, but this would increase staff
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workload, whilst also introducing further complexity.
The performance of NEWS in this study is similar to that of the
original derivation study for NEWS (AUROC, 0.89) [22] supporting
previous external evaluations of the scoring system [32,33] (see ap-
pendix A3 in Supplementary material, which describes the results
considering admissions to each trust, separately).
Strengths
This study focuses on the patient groups for which the new SpO2
Fig. 1. Flowchart showing application of exclusion criteria for obtaining the admissions included in the analysis.
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scoring “scale” in NEWS2 were intended. Robust electronic data cap-
ture allowed us to identify groups of patients admitted with/at risk of
T2RF; this has not previously been undertaken. Unlike previous studies
[32], our study includes vital signs taken throughout the patient’s
hospital journey. The additional analyses, and the TRIPOD statement
Table 1
Demographic descriptors for admissions included in each risk group. T2RF denotes Type II Respiratory Failure.
Documented T2RF At risk T2RF Not at risk T2RF All
Number of admissions 1394 48,898 202,094 251,266
Males,
N (%)
696 (49.9) 23,569 (48.2) 95,736 (47.4) 119,433 (47.5)
Age (years),
median (IQR)
75 (67-83) 72 (60-80) 66 (47-80) 68 (50-80)
Length of stay (days),
median (IQR)
6.7 (3.1-14) 4.0 (1.8-9) 2.8 (1.3-6.8) 3.0 (1.3-7.1)
Charlson Comorbidity Indexa, median (IQR) 7 (4-16) 4 (0-14) 0 (0-8) 0 (0-10)
Elective admissionsa, N (%) 104 (7.5) 9351 (19.1) 49,978 (24.7) 59,374 (23.6)
Surgical admissionsa, N (%) 229 (16.4) 14,833 (30.3) 89,427 (44.3) 104,338 (41.5)
Ethnic category, N (%)
Asian or Asian British 23 (1.6) 281 (0.6) 1850 (0.9) 2136 (0.9)
Black or Black British 1 (0.1) 116 (0.2) 1031 (0.5) 1147 (0.5)
Mixed 9 (0.6) 117 (0.2) 710 (0.4) 828 (0.3)
Other Ethnic Groups 126 (9.0) 4317 (8.8) 29,585 (14.6) 33,936 (13.5)
Not disclosed 5 (0.4) 142 (0.3) 957 (0.5) 1102 (0.4)
White 1230 (88.2) 43,925 (89.8) 167,961 (83.1) 212,117 (84.4)
Primary outcome, N (%)
In-hospital mortality 159 (11.4) 2220 (4.5) 4606 (2.3) 6871 (2.7)
Secondary outcome, N (%)
Unanticipated ICU admission 45 (3.2) 575 (1.2) 1704 (0.8) 2289 (0.9)
Cardiac arrest 18 (1.3) 288 (0.6) 628 (0.3) 920 (0.4)
Number of vital sign sets 61,340 1,466,420 4,751,323 6,229,740
a The Charlson Comorbidity Index, and definitions of surgical specialties and elective admissions were determined according to the methodology and specification
provided by NHS Digital (Charlson Comorbidity Index guidelines are available at https://beta.digital.nhs.uk/publications/ci-hub/summary-hospital-level-mortality-
indicator-shmi).
Fig. 2. Representation of the normalised histograms of oxygen saturation
(SpO2) recorded for each of the risk groups. For each bar, the relative propor-
tion of measurements performed while patients were on oxygen (O2) or on air is
shown.
Table 2
Performance metrics of the two scoring systems (NEWS and NEWS2) for pre-
dicting the primary outcome in the three risk groups, which include the area
under the receiver operating characteristics curve (AUROC), with 95% con-
fidence interval (CI), and sensitivity, specificity and positive predictive value
values at a threshold of 5 and 7. The fourth column (NEWS – NEWS2) indicates
the mean difference (95% CI) between the AUROCs of NEWS and NEWS2. T2RF
denotes Type II Respiratory Failure.
NEWS NEWS2 NEWS – NEWS2
Documented T2RF
AUROC (95% CI) 0.862 (0.848 -
0.875)
0.841 (0.827 -
0.855)
0.021 (0.012 -
0.030)†
Score 5 / Score 7
Sensitivity 90.7 / 73.9 80.9 / 60.1
Specificity 57.8 / 88.8 68.8 / 87.3
Positive predictive value 2.5 / 4.6 3.0 / 5.3
At risk T2RF
AUROC (95% CI) 0.881 (0.878 -
0.884)
0.860 (0.857 -
0.864)
0.021 (0.019 -
0.023)†
Score 5 / Score 7
Sensitivity 78.5 / 57.6 73.2 / 51.8
Specificity 82.4 / 93.9 80.6 / 83.6
Positive predictive
value
3.2 / 6.6 2.7 / 5.7
Not at risk T2RF
AUROC (95% CI) 0.910 (0.907 -
0.912)
0.891 (0.889 -
0.893)
0.019 (0.018 -
0.020)†
Score 5 / Score 7
Sensitivity 72.0 / 51.7 73.5 / 54.5
Specificity 93.6 / 98.1 87.4 / 95.7
Positive predictive
value
5.0 / 11.2 2.7 / 5.7
† Denotes significant difference in AUROC (p < 0.05).
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Fig. 3. Receiver operating characteristic (ROC) curve for NEWS and NEWS2 (with scale2), for discriminating vital signs observations followed by in-hospital death
within the following 24 h for the three risk groups (from top to bottom): admissions with documented type II respiratory failure (T2RF), admissions at risk of T2RF,
and admissions not at risk of T2RF. Sensitivity and 1–Specificity are shown in %.
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that guides our work further strengthen the findings of our study,
promoting both clarity and interpretability.
Limitations
Our study relies on diagnostic codes and records of oxygen pre-
scription to categorise patients with/at risk of T2RF, so patients could
have been missed or misclassified. However, diagnostic coding for
COPD has been shown to be relatively reliable [34], suggesting using
this approach to identify those at risk of T2RF may also be reliable. In
the case of oxygen prescriptions, the prescribing clinician’s assessment
of whether or not the patient is a “carbon dioxide retainer” is recorded,
and it seems likely that the same assessment would underlie the choice
of SpO2 scale used. Our database does not include documentation of
“new confusion”, which is now recommended to be part of the assess-
ment of consciousness on for NEWS2 [12]; hence, we could not take
account of this in our analysis. Nevertheless, as new confusion was not
part of NEWS, our study clearly demonstrates the effect of the differ-
ences in oxygen SpO2 scales between the two systems for patients with
T2RF. Moreover, the absence of this component is unlikely to have a
different effect in the risk groups. By analysing each vital sign set as
independently associated with outcome (allowing comparison with
previous NEWS publications [22,24]) we run the risk of over-re-
presentation of some patient groups. However, previous work [35]
suggests allowing an outcome to be represented only once has little
effect on assessed outcomes. Evaluation of the secondary outcomes
(cardiac arrest and unanticipated ICU admission) in the documented
T2RF group should be interpreted with caution given the small number
of outcomes (< 100).
Implications
We could find no performance benefit of NEWS2 in any diagnostic
group compared to NEWS. If used in error in patients not at risk of
T2RF, NEWS2 generally reduces discrimination compared to NEWS.
Using NEWS2 instead of NEWS for patients with or at risk of T2RF
reduces sensitivity for detecting patients with adverse outcomes.
Improving sensitivity could be achieved by reducing the trigger values
for NEWS2, but this would also increase staff workload.
The recent endorsement by the RCPL and NHS England of the use of
NEWS2 without underpinning evidence makes our study both im-
portant and urgent. Implementing NEWS2 requires additional staff
training, and new multi-coloured charts, both of which are likely to be
costly. The clinical impact of introducing NEWS2 may also have un-
expected clinical consequences, some of which may also have financial
impact.
Applying the same “normal range” to patients with chronically ab-
normal physiology (e.g. COPD or heart failure) is a compelling criticism
of using a single early warning score (EWS). It is certainly at odds with
the interpretation of individual vital signs in clinical practice. However,
this possible advantage needs to be counter-balanced with the simpli-
city of a single system. Applying different scores also creates a more
complex protocol and observation chart, potentially increasing staff
workload [36,37]. Ultimately, increasing score complexity has to be
shown to improve performance for it to be worthwhile.
Our study shows that the modifications made to NEWS2 (specifi-
cally, the alternative SpO2 scale), which increase chart complexity, are
not likely to improve the detection of deterioration and/or reduce false
alarms in patients with chronic respiratory disease.
Conclusion
For patients at risk of, or with documented, T2RF, the changes
proposed in NEWS2 do not improve the detection of adverse outcomes,
including in-hospital death, unanticipated ICU admission, and cardiac
arrest. The intent to account for known physiological differences in
patients with chronic respiratory failure is laudable, as are the re-
commended improvements in the chart for recording oxygen prescrip-
tions. However, the relationship between SpO2 values, oxygen therapy
and the risk of adverse outcomes should be studied further before wide-
scale adoption of NEWS2. In the interim, a more appropriate alternative
to changing the weighting system for NEWS, might be to modify the
clinical care escalation protocol and response to triggering [38].
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0.015 (0.008 -
0.022)†
0.016 (0.012 -
0.020)†
Composite outcome
NEWS 0.835 (0.824 - 0.847) 0.858 (0.855 -
0.861)
0.881 (0.879 -
0.884)
NEWS2 0.830 (0.818 - 0.841) 0.843 (0.840 -
0.847)
0.867 (0.864 -
0.869)
NEWS – NEWS2 0.006 (-0.003 - 0.014) 0.015 (0.013 -
0.016)†
0.015 (0.014 -
0.016)†
a Where number of adverse outcomes is under 100.
† Denotes significant difference in AUROC (p < 0.05).
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Royal College of Physicians of London’s National Early Warning Score
(NEWS) Development and Implementation Group (NEWSDIG), which
developed NEWS. DP assisted the Royal College of Physicians of London
in the analysis of data validating NEWS. PW co-developed the System
for Electronic Notification and Documentation (SEND), for which
Drayson Health has purchased a sole licence. The company has a re-
search agreement with the University of Oxford and royalty agreements
with Oxford University Hospitals NHS Trust and the University of
Oxford. Drayson Health may in the future pay PW personal fees.
Appendix A. Supplementary data
Supplementary material related to this article can be found, in the
online version, at doi:https://doi.org/10.1016/j.resuscitation.2018.09.
026.
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